ask our doctors

Parkinson Disease Dementia

Get the facts on Parkinson Disease Dementia treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Parkinson Disease Dementia prevention, screening, research, statistics and other Parkinson Disease Dementia related topics. We answer all your qestions about Parkinson Disease Dementia.

Question: I am trying to find information about non-medical treatments for parkinson disease dementia, coping mechanism? The neuro-psych tests show what appear to be learning disabilities that were not there before. Since learning disabled people can be helped, is anyone working on this for parkinson dementia? My son, at 53, has had pd for 20 years. He is very bright but realizes his limitations. Help, anyone?

Answer: There are meds to slow it down. My Mother has it. I think that one is called atenol. But other than that, I don't know.


Parkinson Disease Dementia News

Plain Dealer

Vision acuity issues may make dementia seem worse, CWRU study finds
Plain Dealer
 

Parkinson's Disease is Deadlier for Some

dailyRx
Parkinson's disease has many possible symptoms. Researchers have found some groups of Parkinson's patients more often than others have negative outcomes. New research shows that Parkinson's disease patients with dementia die most often, ...
 

Nature.com

Europe experiments with joined-up research
Nature.com
 

Scientific American

Cracks in the Plaques: Mysteries of Alzheimer's Slowly Yielding to New Research
Scientific American
 

Brisbane Times

A look at different types of dementia
TSN
 

DigitalJournal.com

Op-Ed: Recent PD/Dementia Research Proves More Research is Needed
DigitalJournal.com
 

Daily Mail

How 'dementia' can be beaten by a drain in your brain
Daily Mail
 

Dance class beneficial to Parkinson's patients

Tulsa World
Besides tremors, it can cause rigid walking, slowed speech and sometimes dementia. Lee's wife, Melanie, said her husband attends exercise classes three times a week that are meant to keep him active and lessen the effects of the disease.
 

Navidea enters licensing deal with Alseres

Pharmaceutical Business Review
Navidea Biopharmaceuticals has signed an option agreement with Alseres Pharmaceuticals to license [123I]-E-IAFCT Injection, developed as an aid in the diagnosis of Parkinson's disease and movement disorders. [123I]-E-IAFCT Injection also called ...
 

Intellect Neurosciences Files New Patent Applications for Immunotherapy ...

MarketWatch (press release)
RECALL-VAX and CONJUMAB-A have potential applications for treatment of serious diseases such as Alzheimer's, Parkinson's, Huntington's, Cerebral Amyloid Angiopathy, Frontotemporal Dementia, Progressive Supranuclear Palsy, Pick's disease, Cortical Basal ...